Skip to main content
CG Invites Co., Ltd. logo

CG Invites Co., Ltd. — Investor Relations & Filings

Ticker · 083790 ISIN · KR7083790006 KO Manufacturing
Open in API
Filings indexed 450 across all filing types
Latest filing 2024-06-14 Director's Dealing
Country KR South Korea
Listing KO 083790

About CG Invites Co., Ltd.

https://cginvites.com/en

CG Invites Co., Ltd. is a biopharmaceutical company specializing in digital genomics and personalized medicine. The company's activities are focused on four main areas: genomics, personalized cancer vaccines, digital therapeutics, and the development of chemical and biological drugs. It utilizes Whole Genome Sequencing to support precision medicine initiatives and develops mRNA-based personalized cancer vaccines. The company also creates software-based medical interventions, known as digital therapeutics. Its drug development pipeline includes therapeutics for oncology and inflammatory diseases, such as Acelex for osteoarthritis, Ivaltinostat for pancreatic cancer, and Camrelizumab for immuno-oncology. The company's research approach is based on structural chemoproteomics and the integration of genomic data to develop targeted treatments.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. It details specific share transactions (장내매수 - open market purchases) by an executive (Lee Hoyoung) of CG Invites Co., Ltd. This type of filing is classified as 'Director's Dealing' (DIRS) as it reports personal share transactions by company insiders.
2024-06-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. It details the acquisition of shares by an executive (Lee Hoyoung) of CG Invites Co., Ltd. through open market purchases. This type of filing is specifically categorized as 'Director's Dealing' (DIRS) as it reports personal share transactions by company insiders.
2024-05-28 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership, including acquisitions and changes in special relationships, for the company '씨지인바이츠 주식회사'. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2024-05-28 Korean
[첨부추가]주요사항보고서(회사합병결정)
M&A Activity Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean financial authorities regarding a corporate merger (회사합병 결정) between CG Invites and its 100% owned subsidiary, Procagen. This document details the merger method, purpose, timeline, and financial information of the entities involved. Since it is a formal regulatory filing detailing a specific corporate action (merger) rather than a general announcement or a periodic report, it falls under the category of M&A Activity (TAR).
2024-05-16 Korean
분기보고서 (2024.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company '크리스탈지노믹스(주)' (now CG인바이츠) covering the period from January 1, 2024, to March 31, 2024. It contains detailed financial data, business operations, and management disclosures required for a quarterly filing in South Korea. It is not an announcement of a report, but the report itself, containing substantive financial information. Q1 2024
2024-05-14 Korean
기타시장안내(약명및영문명) (영문상호)
Regulatory Filings Classification · 95% confidence The document is a short regulatory notice regarding a change in the company's English name (corporate identity change). It does not fit into specific categories like financial reports, dividends, or director dealings. As it is a general regulatory announcement regarding market information, it falls under the RNS category.
2024-04-22 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.